Martín E. Stryjewski

8.2k total citations
80 papers, 4.6k citations indexed

About

Martín E. Stryjewski is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Martín E. Stryjewski has authored 80 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 31 papers in Epidemiology and 28 papers in Clinical Biochemistry. Recurrent topics in Martín E. Stryjewski's work include Antimicrobial Resistance in Staphylococcus (44 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Streptococcal Infections and Treatments (18 papers). Martín E. Stryjewski is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (44 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Streptococcal Infections and Treatments (18 papers). Martín E. Stryjewski collaborates with scholars based in United States, Argentina and Canada. Martín E. Stryjewski's co-authors include G. Ralph Corey, Vance G. Fowler, Vivian H. Chu, Steven L. Barriere, G. Ralph Corey, Henry F. Chambers, L. Barth Reller, Christopher H. Cabell, Michael M. Kitt and Lynda A. Szczech and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Clinical Infectious Diseases.

In The Last Decade

Martín E. Stryjewski

77 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martín E. Stryjewski United States 35 2.9k 1.5k 1.4k 996 823 80 4.6k
Manel Almela Spain 36 2.3k 0.8× 2.3k 1.6× 1.4k 1.0× 391 0.4× 801 1.0× 111 4.3k
Kenneth H. Rand United States 38 1.5k 0.5× 2.0k 1.3× 681 0.5× 794 0.8× 387 0.5× 122 4.7k
Miquel Pujol Spain 40 1.6k 0.5× 1.7k 1.2× 1.1k 0.8× 682 0.7× 547 0.7× 175 5.2k
Howard S. Gold United States 34 3.2k 1.1× 1.0k 0.7× 1.7k 1.2× 1.4k 1.4× 446 0.5× 72 5.0k
Juan J. Picazo Spain 34 1.9k 0.6× 1.7k 1.2× 1.0k 0.7× 541 0.5× 645 0.8× 156 4.2k
G. Ralph Corey United States 44 3.6k 1.2× 2.9k 2.0× 1.6k 1.1× 671 0.7× 1.5k 1.8× 86 6.6k
Warren E. Rose United States 37 2.4k 0.8× 934 0.6× 1.2k 0.8× 1.1k 1.1× 437 0.5× 130 4.0k
Annie Wong‐Beringer United States 31 2.4k 0.8× 1.2k 0.8× 1.3k 0.9× 637 0.6× 436 0.5× 86 4.3k
Susan Whittier United States 41 1.9k 0.6× 1.5k 1.0× 531 0.4× 820 0.8× 408 0.5× 118 4.7k
Stan Deresinski United States 30 1.9k 0.6× 1.3k 0.9× 556 0.4× 523 0.5× 336 0.4× 106 3.4k

Countries citing papers authored by Martín E. Stryjewski

Since Specialization
Citations

This map shows the geographic impact of Martín E. Stryjewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martín E. Stryjewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martín E. Stryjewski more than expected).

Fields of papers citing papers by Martín E. Stryjewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martín E. Stryjewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martín E. Stryjewski. The network helps show where Martín E. Stryjewski may publish in the future.

Co-authorship network of co-authors of Martín E. Stryjewski

This figure shows the co-authorship network connecting the top 25 collaborators of Martín E. Stryjewski. A scholar is included among the top collaborators of Martín E. Stryjewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martín E. Stryjewski. Martín E. Stryjewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulitta, Jürgen B., Edward Fang, Martín E. Stryjewski, et al.. (2024). Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial Agents and Chemotherapy. 68(4). e0140023–e0140023. 3 indexed citations
2.
Echavarría, Marcela, et al.. (2022). Saliva screening of health care workers for SARS-CoV-2 detection. Revista Argentina de Microbiología. 54(4). 309–313. 2 indexed citations
3.
Maskin, Luis Patricio, et al.. (2021). A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules. CHEST Journal. 160(6). e639–e643. 1 indexed citations
4.
Pryluka, Daniel, et al.. (2020). Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March–June 2020. Emerging infectious diseases. 27(2). 348–351. 28 indexed citations
5.
Doi, Yohei, Robert A. Bonomo, David C. Hooper, et al.. (2017). Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases. 64(suppl_1). S30–S35. 120 indexed citations
6.
Abboud, Cely Saad, Jussimara Monteiro, Martín E. Stryjewski, et al.. (2016). Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics. International Journal of Antimicrobial Agents. 47(5). 386–390. 15 indexed citations
7.
Rubinstein, Eric, et al.. (2014). Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus. Clinical Infectious Diseases. 60(5). 787–796. 23 indexed citations
8.
Barriere, Steven L., Martín E. Stryjewski, G. Ralph Corey, Fredric C. Genter, & Ethan Rubinstein. (2014). Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies. BMC Infectious Diseases. 14(1). 183–183. 32 indexed citations
9.
Fernández, Sebastián P., Lautaro De Vedia, María José López Furst, et al.. (2013). Methicillin-resistant Staphylococcus aureus ST30-SCCmec IVc clone as the major cause of community-acquired invasive infections in Argentina. Infection Genetics and Evolution. 14. 401–405. 28 indexed citations
10.
Rubinstein, Ethan, G. Ralph Corey, Martín E. Stryjewski, & Zeina A. Kanafani. (2011). Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia. Expert Opinion on Pharmacotherapy. 12(17). 2737–2750. 15 indexed citations
11.
Stryjewski, Martín E., Fabián Herrera, Marcela Echavarría, et al.. (2010). Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, Argentina. Scandinavian Journal of Infectious Diseases. 43(1). 70–74. 4 indexed citations
12.
Velez, Digna R., Jamie L. Myers, Martín E. Stryjewski, et al.. (2009). Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.. PubMed. 13(9). 1068–76. 38 indexed citations
13.
Stryjewski, Martín E., Zeina A. Kanafani, Vivian H. Chu, et al.. (2009). Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever. The American Journal of Medicine. 122(3). 281–289.e2. 23 indexed citations
14.
Velez, Digna R., Christian Wejse, Martín E. Stryjewski, et al.. (2009). Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Human Genetics. 127(1). 65–73. 134 indexed citations
15.
Velez, Digna R., William Hulme, Jamie L. Myers, et al.. (2009). NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Human Genetics. 126(5). 643–653. 66 indexed citations
16.
Stryjewski, Martín E., Donald R. Graham, Samuel E. Wilson, et al.. (2008). Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms. Clinical Infectious Diseases. 46(11). 1683–1693. 236 indexed citations
17.
Stryjewski, Martín E., et al.. (2007). Calidad de atención en pacientes diabéticos bajo tratamiento farmacológico. Medicina-buenos Aires. 67(5). 417–422. 2 indexed citations
18.
Stryjewski, Martín E., Russell P. Hall, Vivian H. Chu, et al.. (2007). Expression of Antimicrobial Peptides in the Normal and Involved Skin of Patients with Infective Cellulitis. The Journal of Infectious Diseases. 196(9). 1425–1430. 18 indexed citations
19.
Marriott, Ian, David Gray, Vance G. Fowler, et al.. (2005). Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone. 37(4). 504–512. 62 indexed citations
20.
Cabell, Christopher H., Paul A. Heidenreich, Vivian H. Chu, et al.. (2004). Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999. American Heart Journal. 147(4). 582–586. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026